Study of antiviral nutraceutical PICOVRID in COVID 19 patients
Phase 3
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2020/07/026534
- Lead Sponsor
- Indian Institute of Technology Bombay
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Individuals COVID-19 positive in last 3 days
2. Patients with mild COVID-19 illness as defined in the MOHFW guidelines i.e. fever and or upper respiratory tract infection ,influenza like illness
3. Patients agreeing to provide a written informed consent
4. Patients who agree to reside in the COVID 19 facility during the study
Exclusion Criteria
1. Patients with moderate or severe COVID 19 at the time of recruitment
2. Patients not able to consume drugs orally
3. Patients with uncontrolled hypertension or diabetes mellitus
4. Patients with decompensated liver disease or renal disease
5. Pregnancy or lactation
6. Patients with multiorgan failure
7. Patients undergoing home quarantine during treatment of mild or very mild COVID 19
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method